ASX Announcement

FDA Type C Meeting for SCENESSE in Vitiligo

Published: 01/05/20, 09:33am (AEST)3 pages
Clinuvel Pharmaceuticals Limited
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only